Latest stock market podcasts

Bell Direct

March 20, 2026

In this episode of From the Helm, Grady chats with Alterity Therapeutics (ASX:ATH) CEO David Stamler, to discuss their neurodegenerative disorder treatment specifically targeting Multiple System Atrophy (MSA), a rare and aggressive disease affecting involuntary functions and motor control.

From the helm: Argenica Therapeutics (ASX:AGN), Dr. Liz Dallimore, CEO & MD

Bell Direct

October 1, 2025

From the helm: Cobram Estate Olives (ASX:CBO), Sam Beaton, Co-CEO

Bell Direct

October 1, 2025

From the helm: Cash Converters (ASX:CCV), Sam Budiselik, CEO & MD

Bell Direct

October 1, 2025

From the helm: Metallium (ASX:MTM), Michael Walshe, CEO & MD

Bell Direct

October 1, 2025

Morning Bell 1 October

Bell Direct

October 1, 2025

From the helm: Metal Powder Works (ASX:MPW), John Barnes, Founder & MD

Bell Direct

September 30, 2025

Morning Bell 29 September

Bell Direct

September 29, 2025

Weekly Wrap 26 September

Bell Direct

September 26, 2025

Morning Bell 25 September

Bell Direct

September 25, 2025

Morning Bell 24 September

Bell Direct

September 24, 2025

Morning Bell 23 September

Bell Direct

September 23, 2025

Morning Bell 22 September

Bell Direct

September 22, 2025